The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Demyelination versus remyelination in progressive multiple sclerosis
Abstract
The causes of incomplete remyelination in progressive multiple sclerosis are unknown, as are the pathological correlates of the different clinical characteristics of patients with primary and secondary progressive disease. We analysed brains and spinal cords from 51 patients with progressive multiple sclerosis by planimetry. Thirteen patients with primary progressive disease were compared with 34 with secondary progressive disease. In patients with secondary progressive multiple sclerosis, we found larger brain plaques, more demyelination in total and higher brain loads of active demyelination compared with patients with primary progressive disease. In addition, the brain density of plaques with high-grade inflammation and active demyelination was highest in secondary progressive multiple sclerosis and remained ~18% higher than in primary progressive multiple sclerosis after adjustments for other plaque types and plaque number (P<0.05). Conversely, the proportion of remyelinated shadow plaques (P<0.05) and the overall remyelination capacity (P<0.01) per brain were higher in primary, compared with secondary, progressive multiple sclerosis. By contrast, there were no group differences in the brain load or frequency of low-grade inflammatory plaques with slowly expanding demyelination. Spinal cord lesion loads and remyelination capacity were also comparable in the two patient groups. Remyelinated areas were more vulnerable than the normal-appearing white matter to new demyelination, including active demyelination in secondary progressive multiple sclerosis. 'Recurrent' slowly expanding demyelination, affecting remyelinated areas, and the load of slowly expanding demyelination correlated with incomplete remyelination in both groups. In turn, incomplete remyelination in the spinal cord correlated with higher disease-related disability (determined retrospectively; r = -0.53; P<0.05 for remyelination capacity versus disease severity). By contrast, such a correlation was not observed in the brain. We propose that regulatory and reparative properties could protect the white matter of the brain in patients with primary progressive multiple sclerosis. These patients may, thereby, be spared symptoms until the spinal cord is affected. By contrast, recurrent active demyelination of repaired myelin could explain why similar symptoms often develop in consecutive relapses in relapsing-remitting/secondary progressive multiple sclerosis. Our data also indicate that slowly expanding demyelination may irreparably destroy normal and repaired myelin, supporting the concept of slowly expanding demyelination as an important pathological correlate of clinical progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovering Statistics Using SPSS
Field, A. P., & Miles, J. N. V. (2000) · Medical Entomology and Zoology · Cited by 28,288
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Self-citationThe relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citationMultiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity
Roxburgh, R. H. S. R., Seaman, S. R., Masterman, T., Hensiek, A. E., Sawcer, S. J., Vukusic, S., Achiti, I., Confavreux, C., Coustans, M., le Page, E., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000156155.19270.f8 · Cited by 963
Self-citationMultiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Self-citationNatural history of multiple sclerosis: a unifying concept
Confavreux, C., & Vukusic, S. (2006) · Brain · doi:10.1093/brain/awl007 · Cited by 905
Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Primary-progressive multiple sclerosis
Miller, D. H., & Leary, S. M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70243-0 · Cited by 818
Remyelination is extensive in a subset of multiple sclerosis patients
Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., Bruck, W., Lucchinetti, C., & Lassmann, H. (2006) · Brain · doi:10.1093/brain/awl217 · Cited by 807
Self-citationRemyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Immunopathology of secondary‐progressive multiple sclerosis
Prineas, J. W., Kwon, E. E., Cho, E., Sharer, L. R., Barnett, M. H., Oleszak, E. L., Hoffman, B., & Morgan, B. P. (2001) · Annals of Neurology · doi:10.1002/ana.1255 · Cited by 453
Remyelination in multiple sclerosis
Piaton, G., Williams, A., Seilhean, D., & Lubetzki, C. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17530-1 · Cited by 441
Effect of relapses on development of residual deficit in multiple sclerosis
Lublin, F. D., Baier, M., & Cutter, G. (2003) · Neurology · doi:10.1212/01.wnl.0000096175.39831.21 · Cited by 421
Remyelination protects axons from demyelination-associated axon degeneration
Irvine, K. A., & Blakemore, W. F. (2008) · Brain · doi:10.1093/brain/awn080 · Cited by 420
Remyelination capacity of the MS brain decreases with disease chronicity
Goldschmidt, T., Antel, J., König, F. B., Brück, W., & Kuhlmann, T. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a8260a · Cited by 411
Nijeholt, G. (1998) · Brain · doi:10.1093/brain/121.4.687 · Cited by 381
Central remyelination restores secure conduction
SMITH, K. J., BLAKEMORE, W. F., & MCDONALD, W. I. (1979) · Nature · doi:10.1038/280395a0 · Cited by 329
Evangelou, N. (2001) · Brain · doi:10.1093/brain/124.9.1813 · Cited by 323
A comparison of the pathology of primary and secondary progressive multiple sclerosis
Revesz, T., Kidd, D., Thompson, A. J., Barnard, R. O., & McDonald, W. I. (1994) · Brain · doi:10.1093/brain/117.4.759 · Cited by 293
Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS
Huijbregts, S. C. J., Kalkers, N. F., de Sonneville, L. M. J., de Groot, V., Reuling, I. E. W., & Polman, C. H. (2004) · Neurology · doi:10.1212/01.wnl.0000129828.03714.90 · Cited by 277
Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts
DeLuca, G. C. (2004) · Brain · doi:10.1093/brain/awh118 · Cited by 255
Molyneux, P. D., Kappos, L., Polman, C., Pozzilli, C., Barkhof, F., Filippi, M., Yousry, T., Hahn, D., Wagner, K., Ghazi, M., et al. (2000) · Brain · doi:10.1093/brain/123.11.2256 · Cited by 241
Multiple sclerosis: Pathology of recurrent lesions
Prineas, J. W., Barnard, R. O., Revesz, T., Kwon, E. E., Sharer, L., & Cho, E.-S. (1993) · Brain · doi:10.1093/brain/116.3.681 · Cited by 240
Olerup, O., Hillert, J., Fredrikson, S., Olsson, T., Kam-Hansen, S., Möller, E., Carlsson, B., & Wallin, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7113 · Cited by 239
The contribution of demyelination to axonal loss in multiple sclerosis
DeLuca, G. C. (2006) · Brain · doi:10.1093/brain/awl074 · Cited by 231
Inflammation stimulates remyelination in areas of chronic demyelination
Foote, A. K. (2005) · Brain · doi:10.1093/brain/awh417 · Cited by 230
Spinal cord atrophy and disability in MS: A longitudinal study
Stevenson, V. L., Leary, S. M., Losseff, N. A., Parker, G. J. M., Barker, G. J., Husmani, Y., Miller, D. H., & Thompson, A. J. (1998) · Neurology · doi:10.1212/wnl.51.1.234 · Cited by 229
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
Sellebjerg, F., Börnsen, L., Khademi, M., Krakauer, M., Olsson, T., Frederiksen, J. L., & Sørensen, P. S. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c5b457 · Cited by 217
Self-citationMonson, N. L., Cravens, P. D., Frohman, E. M., Hawker, K., & Racke, M. K. (2005) · Archives of Neurology · doi:10.1001/archneur.62.2.258 · Cited by 210
Remyelination in multiple sclerosis
Brück, W., Kuhlmann, T., & Stadelmann, C. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00191-0 · Cited by 200
Lectures on Diseases of the Nervous System
Bauduy, J. K. (1876) · The American Journal of the Medical Sciences · doi:10.1097/00000441-187601000-00027 · Cited by 197
Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis
Comi, G., Filippi, M., Martinelli, V., Campi, A., Rodegher, M., Alberoni, M., Sirabian, G., & Canal, N. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00168-2 · Cited by 185
Bergendal, G., Fredrikson, S., & Almkvist, O. (2007) · European Neurology · doi:10.1159/000099158 · Cited by 184
Primary and transitional progressive MS: A clinical and MRI cross-sectional study
Stevenson, V. L., Miller, D. H., Rovaris, M., Barkhof, F., Brochet, B., Dousset, V., Dousset, V., Filippi, M., Montalban, X., Polman, C. H., et al. (1999) · Neurology · doi:10.1212/wnl.52.4.839 · Cited by 177
In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study
Agosta, F., Absinta, M., Sormani, M. P., Ghezzi, A., Bertolotto, A., Montanari, E., Comı, G., & Filippi, M. (2007) · Brain · doi:10.1093/brain/awm110 · Cited by 167
Juhler, M., Barry, D. I., Offner, H., Konat, G. W., Klinken, L., & Paulson, O. B. (1984) · Brain Research · doi:10.1016/0006-8993(84)90249-x · Cited by 131
Silwedel, C., & Förster, C. Y. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.06.019 · Cited by 125
Tallantyre, E. C., Bo, L., Al-Rawashdeh, O., Owens, T., Polman, C. H., Lowe, J., & Evangelou, N. (2009) · Brain · doi:10.1093/brain/awp106 · Cited by 93 · cited 1×
“However, one recent pathological study showed less white matter demyelination in the cervical cords in PPMS compared with SPMS (Tallantyre et al., 2009).”
ResultAn immunogenetic heterogeneity in multiple sclerosis.
Hillert, J. A., Grønning, M., Nyland, H., Link, H., & Olerup, O. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.10.887 · Cited by 76
Chari, D. M., & Blakemore, W. F. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms842oa · Cited by 69
Overview of European pilot study of interferon b-1b in primary progressive multiple sclerosis
Montalbán, X. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1033oa · Cited by 57
Lectures ON DISEASES OF THE NERVOUS SYSTEM.
(1872) · The Lancet · doi:10.1016/s0140-6736(02)56679-4 · Cited by 32
Fatal neurogenic pulmonary edema in a patient with progressive multiple sclerosis
Bramow, S., Faber-Rod, J., Jacobsen, C., Kutzelnigg, A., Patrikios, P. T., Sørensen, P. S., Lassmann, H., & Laursen, H. B. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507087848 · Cited by 25
Self-citationPredictors of the location of multiple sclerosis relapse
Deen, S., Bacchetti, P., High, A. S., & Waubant, E. L. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.136440 · Cited by 20
(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Pathological mechanisms in progressive multiple sclerosis
Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,137
Self-citationProgressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Self-citationLassmann, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028936 · Cited by 937
Self-citationFrischer, J. M., Weigand, S. D., Guo, Y., Kale, N., Parisi, J. E., Pirko, I., Mandrekar, J., Bramow, S., Metz, I., Brück, W., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24497 · Cited by 728
Self-citationMyelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Metadata
- Authors
- Bramow, S., Frischer, J. M., Lassmann, H., Koch-Henriksen, N., Lucchinetti, C. F., Sørensen, P. S., & Laursen, H.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-09-20
- Volume
- 133
- Issue
- 10
- Pages
- 2983-2998
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2097866416
- Cited by
- 319
- References
- 47
- FWCI
- 10.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.